CoChat
Sign Up
Cited by 117Probiotics and Fermented FoodsHIV Research and TreatmentReproductive tract infections research

Effect of 25 weeks probiotic supplementation on immune function of HIV patients

Open access
Hummelen, Ruben, Changalucha, John, Butamanya, Nicodemus L., Koyama, Tara E., Cook, Adrian, Habbema, J. Dik F., Reid, Gregor·2011·Gut Microbes
DOI 10.4161/gmic.2.2.15787
Open this paper in CoChat — free account

Abstract

INTRODUCTION: Studies with a follow-up of < 8 weeks have indicated immune-preserving effects of yogurt probiotic supplementation among HIV patients. To evaluate the impact of 25 weeks use of probiotics, a randomized, double blind, controlled study was undertaken on 65 women who were naïve to anti-retroviral treatment. RESULTS: Ten participants were excluded post-randomization due to non-eligibility. Thirty participants were assigned placebo, of whom 25 completed the study versus 19 of 25 completing the study in the probiotics group (p = 0.5). From baseline to 10 weeks follow-up, the CD4 count declined on average 3 CD4 cells/μl (95% Confidence Interval: -97; 91) with placebo versus an increase of 50 cells/μl (95% CI: -61; 162) with probiotics (p = 0.5). From baseline to 25 weeks, the CD4 count increased with 19 cells/μl (95% CI: -90; 129) in the placebo group versus 46 cells/μl (95% CI: -100; 192) with probiotics (p = 0.8). No differences in immune markers, diarrhea incidence or adverse events were observed. DISCUSSION: Lactobacillus GR-1 and RC-14 may be safely consumed at 2 x 10(9) CFU/day by moderately immune compromised HIV patients but this did not universally preserve immune-function. PATIENTS AND METHODS: Women were randomized to receive oral capsules containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 (2 x 10(9) colony forming units) or placebo twice daily for 25 weeks. The CD4 count and immune markers (IgG, IgE, IFNγ and IL-10) were measured at baseline and during follow-up, the occurrence of diarrhea was reported daily.

Integrity signals

Registry

Crossref · 10.4161/gmic.2.2.15787

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Probiotic interventions promote tolerogenicity, can replace pathogenic strains, and reduce inflammation, so T cell depletion and senescence could be reduced in HIV patients.

    “Probiotic interventions have become an interesting therapeutic target for HIV patients because they promote tolerogenicity [169], can replace pathogenic strains, and reduce inflammation [170]; consequently, T cell depletion and senescence could be reduced.”

    From The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties (2024) · cites this paper as [170]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Hummelen, R., Changalucha, J., Butamanya, N. L., Koyama, T. E., Cook, A., Habbema, J. D. F., & Reid, G.
Affiliations
Lawson Health Research Institute (CA)
Corresponding author
Hummelen, Ruben
ORCID
Venue
Gut Microbes
Publisher
Informa UK Limited
Published
2011-03-28
Volume
2
Issue
2
Pages
80-85
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
DOI
10.4161/gmic.2.2.15787
OpenAlex
W2112914354
Cited by
117
References
31
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 10 · 2013: 12 · 2012: 9
FWCI
16.35
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Gut Microbes (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Advanced Foods and Materials Network
  • Danone Institute of Canada
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
probiotics, HIV, immune function, CD4 count, Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC-14, women, immunological markers, diarrhea, untreated HIV patients
MeSH terms
Administration, Oral, Adult, Diet Therapy, Female, Humans, Immunologic Factors, Placebos, HIV Infections, CD4 Lymphocyte Count, Probiotics, Lacticaseibacillus rhamnosus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review